Drug application

GABAPENTIN (GABAPENTIN)

Drugs@FDA ANDA 075428 · SANDOZ

Key facts

Drug name GABAPENTIN
Active ingredients GABAPENTIN
Application type ANDA
Application number 075428
Company SANDOZ
Dosage forms CAPSULE, ORAL
Strength 100MG
Marketing status Discontinued
Reference listed drug No
Latest submission status date Jan 24, 2006

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications